Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
quaternary ammonium cation
|
| gptkbp:affects |
neural excitability
action potential duration |
| gptkbp:block |
voltage-gated potassium channels
|
| gptkbp:CASNumber |
56-34-8
|
| gptkbp:charge |
+1
|
| gptkbp:chemicalFormula |
C8H20N+
|
| gptkbp:has_toxicity |
toxic if ingested
|
| gptkbp:hasInChIKey |
InChI=1S/C8H20N/c1-5-9(6-2,7-3)8-4/h5-8H2,1-4H3/q+1
|
| gptkbp:hasSMILES |
[N+](CC)(CC)(CC)CC
|
| https://www.w3.org/2000/01/rdf-schema#label |
tetraethylammonium
|
| gptkbp:is_found_as |
tetraethylammonium bromide
tetraethylammonium chloride tetraethylammonium hydroxide tetraethylammonium iodide |
| gptkbp:is_synthesized_by |
alkylation of ammonia with ethyl halides
|
| gptkbp:isSolubleIn |
gptkb:water
ethanol |
| gptkbp:IUPACName |
tetraethylazanium
|
| gptkbp:meltingPoint |
varies by salt form
|
| gptkbp:molecularWeight |
130.25 g/mol
|
| gptkbp:PubChem_CID |
CHEBI:27384
12007 |
| gptkbp:used_in |
neuroscience research
physiology research |
| gptkbp:usedFor |
potassium channel blocker
pharmacological tool |
| gptkbp:bfsParent |
gptkb:potassium_channels
gptkb:voltage-gated_potassium_channel gptkb:hOCT2 gptkb:SLC22A1 |
| gptkbp:bfsLayer |
7
|